NCT03939169

Brief Summary

Out of the most commonly performed procedures in neonates, naso-gastric tube insertion is rated as the fifth most painful. The pain is often under estimated due to the frequency with which the procedure is carried out. It has been shown that the environment in which the procedure is performed (e.g with skin to skin contact and specific positioning), reduces the discomfort felt by the newborn. However, this has not yet been proven with regards to naso-gastric tube insertion.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 6, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

November 15, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2020

Completed
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

April 30, 2019

Last Update Submit

January 22, 2026

Conditions

Keywords

painnaso-gastric tube

Outcome Measures

Primary Outcomes (1)

  • Pain during insertion of the probe

    Evaluation of the newborn's pain during insertion of the naso-gastric tube using the Premature Infant Pain Profile (PIPP) scale. The PIPP consists of 3 behavioral (facial actions: brow bulge, eye squeeze, and nasolabial furrow) and 2 physiological (heart rate and oxygen saturation) indicators, and 2 contextual \[gestational age (GA) and behavioral state\] variables that modify pain. In the same time, the heart rate and oxygen saturation of the newborns were measured using a pulse oximeter.

    Day 1

Secondary Outcomes (5)

  • Evaluation of pain using the DAN scale

    Day 1

  • Maternal satisfaction

    Day 1

  • Professional's satisfaction

    Day 1

  • Duration of the Naso -gastric tube in situ

    Day 7

  • Procedure time

    Day 1

Study Arms (4)

Skin-to-skin support

OTHER

The newborn is dressed in one layer of clothing with a hat, he is placed in the ventral position directly on the mother's chest, covered with a warm blanket and held in place with a band during the insertion of the naso-gastric feeding tube.

Other: Installation of a naso-gastric feeding tube

Holding

OTHER

The newborn is held in his mother's arms during insertion of the naso-gastric feeding tube.

Other: Installation of a naso-gastric feeding tube

Four hands care

OTHER

Carried out by two professionals: one health-care professional supports the child and helps stabilize the newborn whilst the other professional inserts the naso-gastric feeding tube.

Other: Installation of a naso-gastric feeding tube

Containing support with equipment

OTHER

Carried out by one healthcare Professional, who places the newborn in such a manner that he will be held in the optimum position (using a soft sheet) during the insertion of the naso-gastric feeding tube.

Other: Installation of a naso-gastric feeding tube

Interventions

Insertion of the feeding tube with skin-to-skin contact or whilst being held in the mother's arms, or by using the four hands technique or by performing positional support with appropriate equipment

Containing support with equipmentFour hands careHoldingSkin-to-skin support

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Preterm baby born between the 32th and the 35th weeks of amenorrhea plus 6 days
  • Prescription of enteral nutrition via naso-gastric tube
  • Naso-gastric tube in-situ
  • Informed consent of both parents

You may not qualify if:

  • For the newborn
  • Under respiratory assistance
  • With nasal or buccal malformation
  • With abnormal heart rhythm or congenital heart disease
  • With hemodynamic instability
  • Transfer to type 3 neonatal unit
  • With a DAN score \> 0 before treatment
  • With an umbilical venous catheter in-situ
  • Fed with thickened milk
  • Prescription of analgesic medications
  • For the parents
  • Minor
  • Under legal protection
  • Difficulties which do not permit the mother to carry out skin-to skin contact or holding support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHR Metz Thionville

Metz, 57085, France

Location

MeSH Terms

Conditions

Premature BirthPain

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2019

First Posted

May 6, 2019

Study Start

November 15, 2019

Primary Completion

November 13, 2020

Study Completion

November 13, 2020

Last Updated

January 23, 2026

Record last verified: 2026-01

Locations